Pender Ventures partner Isaac Souweine leaves VC firm
“Mutual” decision leaves Souweine searching for new opportunities in Canadian tech.
Healthtech
Wittington Ventures hires former MaRS IAF leader Zeeshan Ali as partner
Weston-backed VC adds Ali to help lead its cleantech and healthtech innovation fund.
Elon Musk brings Neuralink brain implants to Toronto in global first
Surgeries were the first the company has tried outside of the US.
Ontario bets on made-in-province healthtech with streamlined Innovation Pathway
Industry leaders say program could be “turning point” for Ontario’s health system.
FDA approval marks “most significant milestone” in Kardium’s history
Burnaby firm gets US green light for innovative system to treat atrial fibrillation.
Inside the platform powering a women’s health uprising
Femtech Canada and Innovation Factory are turning a founder network into a national force.
Molecular You secures $6.9 million CAD to scale predictive blood tests across North America
Fresh funding follows US launch of direct-to-consumer platform.
Vistara Growth wants out of “tweener” category as private credit firm gears up to close fifth fund
BC firm has raised $370 million CAD for Fund V amid an increasingly hot venture debt market.
Proposed SR&ED changes could boost tech companies and national productivity, experts say
Both private and public Canadian companies could claim capital expenditures again if legislation advances.
MaRS and U of T seek new partner as Johnson & Johnson pulls support for JLabs Toronto
Toronto became home to the pharma giant’s first innovation space outside of the US in 2016. Now it’s leaving.
Healwell plans to offload research, patient businesses as it focuses on AI
Both Healwell and parent company Well Health reported record earnings in Q2.
Pathway acquired by US telehealth firm Doximity for $63 million USD
Doximity now beta testing a product with Pathway’s AI-powered search technology and medical datasets.
Femtech Canada hopes to bring women’s healthtech to market through its first commercialization program
Program provides $20,000 in commercialization assistance services from physician groups and contract organizations.
Eyam Health strikes partnership with Swiss non-profit to develop one-dollar malaria treatment
Eyam claims its AI drug discovery and delivery platform can develop treatment at less than half the usual cost.
BC shuffles cabinet, moving Rick Glumac to AI and Ravi Kahlon back to jobs
Province loses JEDI, gains AI minister as premier swears in team “to meet the current moment.”